S10 E12: Inside GU Oncology with Uromigos Co-Host
Published Date:
With podcast host, Ginger Blackmon, and featuring Uromigos Co-Host Brian I. Rini, MD, FASCO.
From bladder cancer treatment breakthroughs to the realities of implementing new therapies in practice, this episode of the PQI Podcast takes a practical look at how quickly GU oncology is evolving — and what that means for oncology teams trying to keep up.
Brian I. Rini, MD, FASCO, Ingram Professor of Medicine at Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, joins the podcast to reflect on the evolution of GU cancer care throughout his career, including the rapid expansion of ADCs, immunotherapy combinations, radio ligands, cellular therapies, and targeted treatments across bladder, kidney, and prostate cancer.
Highlights from the conversation include:
- Why bladder cancer treatment has changed more dramatically than ever before
- The real-world learning curve that comes with new therapies and toxicity management
- Challenges community oncology teams face in keeping pace with rapidly changing data
- The growing role of pharmacists, nurses, and multidisciplinary collaboration in GU care
- How Uromigos started “on a whim” and became a trusted resource for practical GU oncology conversations
Dr. Rini also shares candid perspective on the future of GU oncology, the need for better biomarkers, and why education and communication remain essential as treatment complexity continues to grow.
Listen to Uromigos here.